The Clorox Company logo

The Clorox Company (CLX)

Market Closed
3 Mar, 20:00
NYSE NYSE
$
121. 15
-5.66
-4.46%
$
15.51B Market Cap
- P/E Ratio
4.88% Div Yield
1,772,395 Volume
- Eps
$ 126.81
Previous Close
Day Range
120.64 125.97
Year Range
96.66 153.9
Want to track CLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CLX earnings report is expected in 61 days (4 May 2026)
Clorox Is Overpriced Versus Other Consumer Staples Stocks (Rating Downgrade)

Clorox Is Overpriced Versus Other Consumer Staples Stocks (Rating Downgrade)

The consumer staples sector has struggled due to rising costs, e-commerce, and consumer resistance to price hikes, lagging significantly behind the S&P 500. The Clorox Company might seem like an opportunity, but its shares are expensive compared to other staples names. Clorox faces the same long-term issues as the sector, such as margin compression and competition from store brands.

Seekingalpha | 1 year ago
Clorox Gears Up for Upcoming Q2 Earnings: Here's What You Should Know

Clorox Gears Up for Upcoming Q2 Earnings: Here's What You Should Know

CLX is poised for growth as its IGNITE Strategy drives innovation, efficiency and international expansion amid a challenging market.

Zacks | 1 year ago
Clorox Trading Above 200-Day SMA: Is the Stock Worth Buying?

Clorox Trading Above 200-Day SMA: Is the Stock Worth Buying?

CLX looks poised for growth through recent recovery, improved distribution channels and focus on innovation and expansion despite facing some cost challenges.

Zacks | 1 year ago
Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Clorox (CLX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Why Clorox (CLX) Could Beat Earnings Estimates Again

Why Clorox (CLX) Could Beat Earnings Estimates Again

Clorox (CLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 year ago
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks | 1 year ago
Buy 4 Consumer Staples Stocks to Navigate Market Volatility

Buy 4 Consumer Staples Stocks to Navigate Market Volatility

Consumer staple stocks like CLX, MO, OLLI and TSN are a safe bet during times of market volatility.

Zacks | 1 year ago
1 Magnificent S&P 500 Dividend Stock Down 33% to Buy in 2025 for a Lifetime of Passive Income

1 Magnificent S&P 500 Dividend Stock Down 33% to Buy in 2025 for a Lifetime of Passive Income

Consumer staples behemoth Clorox (CLX 0.58%) has faced no shortage of issues over the last few years. With ballooning inflation and a cyberattack hampering Clorox's operations (among many other companies), the company's stock still languishes 33% below its all-time highs from 2020.

Fool | 1 year ago
Clorox Stock Rises 23% in Six Months: Is it Time to Buy or Avoid?

Clorox Stock Rises 23% in Six Months: Is it Time to Buy or Avoid?

CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.

Zacks | 1 year ago
Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?

Are Consumer Staples Stocks Lagging Clorox (CLX) This Year?

Here is how Clorox (CLX) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.

Zacks | 1 year ago
Fed Signals Fewer Rate Cuts in 2025: 4 Low-Beta Staples Stocks to Buy

Fed Signals Fewer Rate Cuts in 2025: 4 Low-Beta Staples Stocks to Buy

Consumer staple stocks like TSN, UNFI, INGR and CLX that belong to the defensive space are a safe bet during times of market volatility.

Zacks | 1 year ago
Clorox Gains 20.5% in Past Six Months: Time to Buy or Hold the Stock?

Clorox Gains 20.5% in Past Six Months: Time to Buy or Hold the Stock?

CLX benefits from robust pricing and cost-saving initiatives. The company's IGNITE strategy also bodes well.

Zacks | 1 year ago
Loading...
Load More